ANDREA DUFOUR: Open Payments
NPI 1679021273 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 37 payments from 9 companies in 2025. Trend: 2023 $928 · 2024 $1,001 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $178 |
| Janssen Biotech, Inc. | 7 | $160 |
| QOL Medical, LLC | 2 | $100 |
| Madrigal Pharmaceuticals | 2 | $85 |
| Phathom Pharmaceuticals, Inc. | 6 | $84 |
| Exact Sciences Corporation | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Celltrion USA Inc. | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $22 |
Products named: TREMFYA, Sucraid, REZDIFFRA, VOQUEZNA, SKYRIZI, Cologuard Collection Kit, LINZESS, ENTYVIO.
Industry payments across MA — which companies pay providers there.
